Preoperative treatment of patients with locally advanced unresectable rectal adenocarcinoma utilizing continuous chronobiologically shaped 5-fluorouracil infusion and radiation therapy
Open Access
- 15 July 1996
- Vol. 78 (2) , 217-225
- https://doi.org/10.1002/(sici)1097-0142(19960715)78:2<217::aid-cncr5>3.0.co;2-i
Abstract
BACKGROUND This study was designed to determine the efficacy and maximally tolerated dose of 5-fluorouracil when administered by chronobiologically shaped prolonged infusion in combination with radiation therapy in patients with both locally advanced and unresectable rectal carcinoma. METHODS Eighteen sequential patients determined clinically to have either locally advanced or unresectable rectal carcinoma were treated by 4500 centigray (cGy) or 5580 cGy, respectively, combined with continuous chronobiologically modulated 5-FU infusion starting at 250 mg/m2/day, with the dose escalating in each cohort of 5 patients if no Grade 3 or higher toxicity was observed in each cohort. Imaging studies were obtained prior to and after completion of treatment. RESULTS All 18 patients completed the full course of radiation therapy and all were subsequently resectable for potential cure. The maximum tolerated dose of 5-FU was 275/m2/day for 5 weeks. Seven patients had a sphincter-sparing procedure, and ten patients underwent an abdominoperineal resection, all with clear margins. Five complete pathologic responses (28%) were obtained. The average follow-up time was 12 months with a range of 6 to 37 months. With the exception of two patients, one of whom declined surgery and one of whom died of widespread disease, all of the patients have remained free of disease. CONCLUSIONS The combination of radiation therapy and continuous chronobiologically shaped 5-FU infusion at a dose of up to 275/m2/day is well tolerated and appears to be more effective in downsizing and possibly downstaging locally advanced and unresectable rectal carcinoma than radiation therapy alone. Longer follow-up will determine whether ultimate disease free and overall survival are improved by this method. Cancer 1996;78:217-25.Keywords
This publication has 27 references indexed in Scilit:
- Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiationInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Improved therapeutic ratio with protracted venous infusion (PVI) 5-fluorouracil (5FU) during postoperative external beam radiotherapy for high-risk rectal cancerInternational Journal of Radiation Oncology*Biology*Physics, 1993
- Does Preoperative Radiation Therapy Enhance the Probability of Local Control and Survival in High-risk Distal Rectal Cancer?Annals of Surgery, 1992
- Effective Surgical Adjuvant Therapy for High-Risk Rectal CarcinomaNew England Journal of Medicine, 1991
- 5-Fluorouracil modulation of radiosensitivity in cultured human carcinoma cellsInternational Journal of Radiation Oncology*Biology*Physics, 1991
- Preoperative staging of rectal carcinoma with MR imaging: surgical and histopathologic correlation.Radiology, 1990
- Preoperative Radiotherapy as Adjuvant Treatment in Rectal CancerAnnals of Surgery, 1988
- Postoperative Adjuvant Chemotherapy or Radiation Therapy for Rectal Cancer: Results From NSABP Protocol R-011JNCI Journal of the National Cancer Institute, 1988
- Preoperative irradiation for unresectable rectal and rectosigmoid carcinomasCancer, 1983
- Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-fluorouracil or ftorafur and X raysInternational Journal of Radiation Oncology*Biology*Physics, 1982